drugset / Trial / NCT05417776

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

NCT05417776

Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The goal of this study is to investigate the ability of \[68Ga\]CBP8 to detect collagen deposition in early interstitial lung disease.

Timeline

Start
2022-09-28
Primary completion
2026-10-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject [68Ga]CBP8 Diagnostic / imaging agent 350 mbq Intravenous
Background Gadoterate meglumine Diagnostic / imaging agent